Opendata, web and dolomites

GET-UP BAT

GPCR Exploitation To Unlock the Power of Brown/Beige Adipose Tissue

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GET-UP BAT project word cloud

Explore the words cloud of the GET-UP BAT project. It provides you a very rough idea of what is the project "GET-UP BAT" about.

cardiovascular    burning    tangible    worldwide    administration    maximize    position    platforms    adipose    ligand    alternatives    functions    found    discovery    desperately    compounds    gpcr    societal    treatment    ip    combined    vivo    poc    diminish    oxygen    ipr    insulin    options    therapeutic    diabetes    bodyweight    scope    starting    seek    tissue    lived    validated    millions    grant    patentable    quality    critical    treat    erc    sensitivity    class    assembled    people    consequently    strategy    consumption    lowered    analogues    team    harness    attempts    suffer    hundreds    initial    expectancy    cells    activation    holds    experts    economic    combination    extend    poised    glucose    gcprs    benefit    adverse    metabolic    obesity    beige    longer    largely    screen    life    head    protein    brown    disease    obese    strengthen    linked    adrenergic    innovation    diseases    beta    ideally    pharmacology    consuming    treating    hindered    performed    mice    vitro    calorie    strategies    coupled    bat    receptors    uncovering    acrobat    unfortunately    commercial    peptide    enormous    observing   

Project "GET-UP BAT" data sheet

The following table provides information about the project.

Coordinator
KOBENHAVNS UNIVERSITET 

Organization address
address: NORREGADE 10
city: KOBENHAVN
postcode: 1165
website: www.ku.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 149˙986 €
 EC max contribution 149˙986 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) coordinator 149˙986.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Hundreds of millions of people suffer from obesity and diabetes worldwide. These diseases diminish both life quality and expectancy and new treatment strategies are desperately needed. One possible approach is to target the calorie-burning and glucose-consuming functions of brown and beige adipose tissue (B/BAT). Previous attempts to harness the therapeutic potential of B/BAT have largely focused on the β-adrenergic class of G protein-coupled receptors (GCPRs). Unfortunately, these methods are hindered by adverse cardiovascular side effects linked to adrenergic activation. Therefore, uncovering non-adrenergic alternatives to exploit B/BAT for treating metabolic disease holds the potential for enormous societal and economic benefit.

Here, we propose the activation of one such non-adrenergic GPCR on B/BAT as a means to treat obesity and diabetes. We identified this GPCR from a screen of B/BAT receptors performed in my ERC Starting Grant project, aCROBAT. We found that treating brown adipose cells with the peptide ligand for this GPCR increased oxygen consumption. We recognized the therapeutic potential after observing that ligand administration in vivo lowered bodyweight and improved insulin sensitivity in obese mice. However, the resources required to develop this discovery into a tangible innovation extend beyond the scope of aCROBAT.

Consequently, I’m applying for an ERC PoC grant for critical support to take the initial steps to commercial application. Specifically, we seek to strengthen our IP position by developing patentable, longer-lived analogues of the ligand. Importantly, we will test these lead compounds head-to-head and in combination with current treatment options. We have assembled a team of experts to address key aspects from peptide design and pharmacology to IPR strategy and commercial development. Combined with our validated in vitro and in vivo testing platforms, we are ideally poised to maximize innovation potential.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GET-UP BAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GET-UP BAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

EVOCELFATE (2019)

Evolution of cell fate specification modes in spiral cleavage

Read More  

HydroLieve (2018)

A long-lasting non-migrating hydrogel for relieving chronic pain

Read More  

E-DURA (2018)

Commercialization of novel soft neural interfaces

Read More